http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103327977-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate | 2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103327977-B |
| titleOfInvention | Dyscrasic treatment or prophylactic |
| abstract | The object of this invention is to provide as dyscrasic treatment or the useful new medicine of prophylactic, described dyscrasia be in the chronic disease of malignant tumour, tuberculosis, diabetes, hematologic disease, endocrine system disease, infection disease, aids etc., losing weight significantly, anaemia, edema, poor appetite, asthenia universalis, taediumvitae etc. be the general syndrome of primary symptom shape. The invention provides and contain on the compound with morphinan skeleton using the compound of following structure as representative or its pharmacology acceptable acid-addition salts as dyscrasic treatment or the prophylactic of active ingredient. |
| priorityDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.